Earnings Summary

Anixa Biosciences, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2024. On a quarterly growth basis, Anixa Biosciences, Inc. has generated -100% fall in its revenue since last 3-months.

Anixa Biosciences, Inc.’s net profit fell -53.54% since last year same period to $-3.26Mn in the Q1 2024. On a quarterly growth basis, Anixa Biosciences, Inc. has generated -21% fall in its net profits since last 3-months.

Anixa Biosciences, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2024. On a quarterly growth basis, Anixa Biosciences, Inc. has generated -Inf% fall in its net profit margins since last 3-months.

Anixa Biosciences, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.09 - a 0% jump from last quarter’s estimates.

Anixa Biosciences, Inc.’s earning per share (EPS) estimates for the current year stand at -0.09.

Anixa Biosciences, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2024. This indicates that the Anixa Biosciences, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.